BOUNDLESS BIO, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-23.7M | $-13.6M | $-12.9M | $-13.9M | $-15.7M | $-15.8M | $-16.4M | $-16.5M |
| Depreciation & Amortization | $1.3M | $284.0K | $334.0K | $300.0K | $300.0K | $317.0K | $223.0K | $300.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.2M | $1.4M | $1.3M | $1.3M | $1.7M | $1.8M | $2.0M | $2.0M |
| Net Cash from Operating Activities | $-21.0M | $-15.0M | $-10.1M | $-10.2M | $-11.8M | $-14.5M | $-15.6M | $-13.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $38.0K | $8.0K | $424.0K | $15.0K | $48.0K | $59.0K | $466.0K | $483.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $23.1M | $14.6M | $13.0M | $10.5M | $11.3M | $3.1M | $1.8M | $22.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | $113.0K | $-13.0K |
| Net Change in Cash | $2.2M | $-385.0K | $2.9M | $283.0K | $-420.0K | $-11.5M | $-13.6M | $8.9M |
| Free Cash Flow | $-21.0M | $-15.0M | $-10.5M | $-10.2M | $-11.9M | $-14.6M | $-16.0M | $-13.7M |